Blood cancers, Hodgkin lymphoma, Lymphoma
Results
Phase 1
This trial looked at increasing the dose of doxorubicin in a chemotherapy drug combination called ABVD for Hodgkin lymphoma. This trial was supported by Cancer Research UK.
Recruitment start: 23 January 2009
Recruitment end: 30 May 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor John Radford
Amgen
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Paterson Institute for Cancer Research
The Christie NHS Foundation Trust
This is Cancer Research UK trial number CRUK/08/013.
Last reviewed: 26 May 2014
CRUK internal database number: 2856
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
